| 1 | about adlm media adlm | | | | | | | 2 | 0.25% |
| 2 | media adlm 2024 career | | | | | | | 2 | 0.25% |
| 3 | adlm media adlm 2024 | | | | | | | 2 | 0.25% |
| 4 | adlm artery conversation discrepancy | | | | | | | 1 | 0.13% |
| 5 | as high as recent | | | | | | | 1 | 0.13% |
| 6 | high as recent studies | | | | | | | 1 | 0.13% |
| 7 | indicate read here featured | | | | | | | 1 | 0.13% |
| 8 | read here featured adlm | | | | | | | 1 | 0.13% |
| 9 | here featured adlm artery | | | | | | | 1 | 0.13% |
| 10 | featured adlm artery conversation | | | | | | | 1 | 0.13% |
| 11 | discrepancy in lactate values | | | | | | | 1 | 0.13% |
| 12 | artery conversation discrepancy in | | | | | | | 1 | 0.13% |
| 13 | actually be as high | | | | | | | 1 | 0.13% |
| 14 | lactate values arterians help | | | | | | | 1 | 0.13% |
| 15 | values arterians help a | | | | | | | 1 | 0.13% |
| 16 | arterians help a colleague | | | | | | | 1 | 0.13% |
| 17 | help a colleague navigate | | | | | | | 1 | 0.13% |
| 18 | a colleague navigate a | | | | | | | 1 | 0.13% |
| 19 | colleague navigate a case | | | | | | | 1 | 0.13% |
| 20 | be as high as | | | | | | | 1 | 0.13% |
| 21 | might not actually be | | | | | | | 1 | 0.13% |
| 22 | not actually be as | | | | | | | 1 | 0.13% |
| 23 | of tufts university about | | | | | | | 1 | 0.13% |
| 24 | low and middleincome countries | | | | | | | 1 | 0.13% |
| 25 | and middleincome countries cln | | | | | | | 1 | 0.13% |
| 26 | middleincome countries cln spoke | | | | | | | 1 | 0.13% |
| 27 | countries cln spoke to | | | | | | | 1 | 0.13% |
| 28 | cln spoke to dr | | | | | | | 1 | 0.13% |
| 29 | spoke to dr michael | | | | | | | 1 | 0.13% |
| 30 | jordan of tufts university | | | | | | | 1 | 0.13% |
| 31 | tufts university about why | | | | | | | 1 | 0.13% |
| 32 | in lactate values measured | | | | | | | 1 | 0.13% |
| 33 | university about why hiv | | | | | | | 1 | 0.13% |
| 34 | about why hiv drug | | | | | | | 1 | 0.13% |
| 35 | why hiv drug resistance | | | | | | | 1 | 0.13% |
| 36 | hiv drug resistance in | | | | | | | 1 | 0.13% |
| 37 | drug resistance in low | | | | | | | 1 | 0.13% |
| 38 | resistance in low and | | | | | | | 1 | 0.13% |
| 39 | middleincome countries might not | | | | | | | 1 | 0.13% |
| 40 | countries might not actually | | | | | | | 1 | 0.13% |